Literature DB >> 24662133

Radiotherapy- or radical surgery-induced female sexual morbidity in stages IB and II cervical cancer.

Yuko Harding1, Takuma Ooyama, Tomoko Nakamoto, Akihiko Wakayama, Wataru Kudaka, Morihiko Inamine, Yutaka Nagai, Shinichiro Ueda, Yoichi Aoki.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the sexual function in cervical cancer survivors after radiotherapy (RT) or radical surgery (RS).
METHODS: This was an observational and cross-sectional study. The Female Sexual Function Index (FSFI) self-reported questionnaires were distributed to 175 patients after RT (RT group) or RS (RS group) and 521 healthy women (control) between 2011 and 2012. Sexual functions were compared among these 3 groups.
RESULTS: Eligible 92 patients (46 in RT group, 46 in RS group) and 148 control subjects were included for analysis. There was a significant difference in median (range) FSFI total score of 5.5 (3.6-34.7) in the RT group, 18.9 (3.4-31.2) in the RS group, and 22.1 (2-34.2) in the control group (P < 0.001). The median FSFI total score in the RT group was significantly lower than that in the control group (P < 0.001). Six sexual domains (desire, arousal, lubrication, orgasm, satisfaction, pain) were all significantly affected in the RT group, and no significant differences, except pain, were observed in the RS group as compared with the control group.
CONCLUSIONS: Interventions involving counseling and rehabilitation for female sexual function should be provided in cervical cancer survivors, especially after RT.

Entities:  

Mesh:

Year:  2014        PMID: 24662133     DOI: 10.1097/IGC.0000000000000112

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  7 in total

Review 1.  Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations.

Authors:  Gwendolyn P Quinn; Julian A Sanchez; Steven K Sutton; Susan T Vadaparampil; Giang T Nguyen; B Lee Green; Peter A Kanetsky; Matthew B Schabath
Journal:  CA Cancer J Clin       Date:  2015-07-17       Impact factor: 508.702

2.  Evaluation of sexual dysfunction in gynecologic cancer survivors using DSM-5 diagnostic criteria.

Authors:  Hao Lin; Hung-Chun Fu; Chen-Hsuan Wu; Yi-Jen Tsai; Yin-Jou Chou; Chun-Ming Shih; Yu-Che Ou
Journal:  BMC Womens Health       Date:  2022-01-05       Impact factor: 2.809

Review 3.  Sexual dysfunction in women with cancer: a systematic review with meta-analysis of studies using the Female Sexual Function Index.

Authors:  Maria Ida Maiorino; Paolo Chiodini; Giuseppe Bellastella; Dario Giugliano; Katherine Esposito
Journal:  Endocrine       Date:  2015-12-07       Impact factor: 3.633

4.  The Life Quality and Sexual Function of Women Underwent Radical Hysterectomy.

Authors:  Roza Pak; Tolkyn Sadykova; Dilyara Kaidarova; Murat Gultekin; Gulnara Kasimova; Shynar Tanabayeva; Naylia Ussebayeva; Aigul Tazhiyeva; Maksut Senbekov; Ildar Fakhradiyev
Journal:  Asian Pac J Cancer Prev       Date:  2021-02-01

Review 5.  Prevalence of sexual dysfunction in women with cancer: A systematic review and meta-analysis.

Authors:  Seyedeh Esmat Hosseini; Mahnaz Ilkhani; Camelia Rohani; Alireza Nikbakht Nasrabadi; Raza Ghanei Gheshlagh; Ashraf Moini
Journal:  Int J Reprod Biomed       Date:  2022-02-18

Review 6.  Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.

Authors:  Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin
Journal:  Cancer Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.592

Review 7.  Pelvic radiotherapy and sexual function in women.

Authors:  Pernille Tine Jensen; Ligita Paskeviciute Froeding
Journal:  Transl Androl Urol       Date:  2015-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.